FI106202B - Menetelmä lääkeaineina käyttökelpoisten foetidiinien 1 ja 2 valmistamiseksi - Google Patents

Menetelmä lääkeaineina käyttökelpoisten foetidiinien 1 ja 2 valmistamiseksi Download PDF

Info

Publication number
FI106202B
FI106202B FI943294A FI943294A FI106202B FI 106202 B FI106202 B FI 106202B FI 943294 A FI943294 A FI 943294A FI 943294 A FI943294 A FI 943294A FI 106202 B FI106202 B FI 106202B
Authority
FI
Finland
Prior art keywords
yhdiste
methanol
extraction
extract
alkaloids
Prior art date
Application number
FI943294A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943294A0 (fi
FI943294A (fi
Inventor
Giuseppe Mustich
Ezio Bombardelli
Luisella Verotta
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of FI943294A0 publication Critical patent/FI943294A0/fi
Publication of FI943294A publication Critical patent/FI943294A/fi
Application granted granted Critical
Publication of FI106202B publication Critical patent/FI106202B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G5/00—Alkaloids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI943294A 1994-05-30 1994-07-11 Menetelmä lääkeaineina käyttökelpoisten foetidiinien 1 ja 2 valmistamiseksi FI106202B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI941112A IT1269862B (it) 1994-05-30 1994-05-30 Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono
ITMI941112 1994-05-30

Publications (3)

Publication Number Publication Date
FI943294A0 FI943294A0 (fi) 1994-07-11
FI943294A FI943294A (fi) 1995-12-01
FI106202B true FI106202B (fi) 2000-12-15

Family

ID=11369016

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943294A FI106202B (fi) 1994-05-30 1994-07-11 Menetelmä lääkeaineina käyttökelpoisten foetidiinien 1 ja 2 valmistamiseksi

Country Status (20)

Country Link
US (1) US5525609A (es)
EP (1) EP0685481B1 (es)
JP (1) JP3615240B2 (es)
KR (1) KR0149723B1 (es)
CN (1) CN1052233C (es)
AT (1) ATE159527T1 (es)
CA (1) CA2127763C (es)
CZ (1) CZ290320B6 (es)
DE (2) DE69406430T2 (es)
DK (1) DK0685481T3 (es)
ES (1) ES2081783T3 (es)
FI (1) FI106202B (es)
GR (2) GR960300006T1 (es)
HK (1) HK1003833A1 (es)
HU (1) HU216844B (es)
IT (1) IT1269862B (es)
NO (1) NO179640C (es)
PL (1) PL177042B1 (es)
RU (1) RU2123005C1 (es)
SK (1) SK279615B6 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527913A (en) * 1993-02-25 1996-06-18 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds
WO1996011005A2 (en) * 1994-10-06 1996-04-18 Atlas Leon T Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
IT1283635B1 (it) * 1996-05-10 1998-04-23 Indena Spa Composti a scheletro camptotecinico isolati da mappia foetida e loro uso come sintoni per farmaci o come principi attivi
FR2792937B1 (fr) 1999-04-27 2001-08-10 Cemaf NOUVEAUX DERIVES DE PYRROLO-(3,4-b) QUINOLEINE, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT
AUPQ987400A0 (en) * 2000-09-04 2000-09-28 Food Ingredients Technologies Intangibles (Bermuda) Limited Process for selectively extracting bioactive components
AU2003265223A1 (en) * 2002-03-01 2003-12-22 University Of Pittsburgh Mappicine analogs, methods of inhibiting retroviral reverse transcriptase and methods of treating retroviruses
US6893668B2 (en) * 2003-03-31 2005-05-17 Council Of Scientific And Industrial Research Process for isolation of anticancer agent camptothecin from Nothapodytes foetida
US20060135546A1 (en) * 2004-12-16 2006-06-22 Jagadevappa Basavaraja Methods for the purification of 20(S)- camptothecin
CN103181272A (zh) * 2011-12-28 2013-07-03 广东神农衍生物科技有限公司 一种药用原材料臭马比木的人工种植方法
CN104619322B (zh) * 2013-07-24 2016-10-19 张苑金 抗癌药物组合物及其制备方法和用途
CN105053041A (zh) * 2015-08-11 2015-11-18 长沙秋点兵信息科技有限公司 一种用于农作物的杀虫剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6461482A (en) * 1987-08-31 1989-03-08 Yakult Honsha Kk Dehydrocamptothecin and production thereof
EP0540099B1 (en) * 1991-10-29 1996-04-17 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
EP0556585A3 (en) * 1992-01-24 1993-09-01 Takeda Chemical Industries, Ltd. Condensed camptothecin derivatives their production and use as antitumor agents
IT1254517B (it) * 1992-03-06 1995-09-25 Indena Spa 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
AP9300587A0 (en) * 1992-11-12 1995-05-05 Glaxo Inc Water soluble camptothecin derivatives.
US5352789A (en) * 1993-02-25 1994-10-04 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds

Also Published As

Publication number Publication date
NO179640C (no) 1996-11-20
EP0685481B1 (en) 1997-10-22
US5525609A (en) 1996-06-11
RU94026100A (ru) 1996-05-27
ATE159527T1 (de) 1997-11-15
NO179640B (no) 1996-08-12
IT1269862B (it) 1997-04-15
HUT71510A (en) 1995-12-28
CZ290320B6 (cs) 2002-07-17
ES2081783T3 (es) 1997-12-16
PL304577A1 (en) 1995-12-11
HU216844B (hu) 1999-09-28
EP0685481A3 (en) 1996-03-06
PL177042B1 (pl) 1999-09-30
CN1121075A (zh) 1996-04-24
FI943294A0 (fi) 1994-07-11
CZ171894A3 (en) 1995-12-13
FI943294A (fi) 1995-12-01
NO942633D0 (no) 1994-07-13
KR950032253A (ko) 1995-12-20
KR0149723B1 (ko) 1998-08-17
NO942633L (no) 1995-12-01
ITMI941112A1 (it) 1995-11-30
GR960300006T1 (en) 1996-02-29
JP3615240B2 (ja) 2005-02-02
DE69406430D1 (de) 1997-11-27
EP0685481A2 (en) 1995-12-06
SK279615B6 (sk) 1999-01-11
GR3025120T3 (en) 1998-01-30
JPH07330772A (ja) 1995-12-19
RU2123005C1 (ru) 1998-12-10
HK1003833A1 (en) 1998-11-06
DE685481T1 (de) 1996-10-10
DE69406430T2 (de) 1998-02-26
CN1052233C (zh) 2000-05-10
ITMI941112A0 (it) 1994-05-30
HU9402089D0 (en) 1994-09-28
DK0685481T3 (da) 1998-05-25
SK83494A3 (en) 1995-12-06
ES2081783T1 (es) 1996-03-16
CA2127763C (en) 1997-02-25
CA2127763A1 (en) 1995-12-01

Similar Documents

Publication Publication Date Title
EP2684884B1 (en) Novel compounds obtained from gamboge resin, and medical uses of the same
JPH02311496A (ja) ドラスタチン１５とその応用
FI106202B (fi) Menetelmä lääkeaineina käyttökelpoisten foetidiinien 1 ja 2 valmistamiseksi
JPH0665675B2 (ja) 新規なブリオスタチン４〜８
JP2009280610A (ja) 腫瘍／癌細胞の増殖の抑制活性を有するガンボージ樹脂から単離した化合物及びその化合物を含む薬学的組成物
CN110343116B (zh) 一种野菊花提取物及其制备方法和在制备治疗鼻咽癌药物中的应用
EP1619195A2 (en) Compounds isolated from gamboge resin having activity in inhibiting the growth of tumor/cancer cells and pharmaceutical compositions comprising the same
EP1963349B1 (en) Novel loganin analogues and a process for the preparation thereof
EP1200444B1 (en) Novel xanthone compounds, their preparation and use as medicament
CN108659089B (zh) 一种具有抗氧化作用的甾醇化合物及其在制备药物中的应用
CN100434419C (zh) 单环多取代饱和环已酮类化合物及其制备方法和用途
CN100577176C (zh) 短瓣金莲花提取物、其抗炎有效成分和它们的用途
FI101042B (fi) Menetelmä kasviperäisten, antineoplastisten, kemoterapeuttisten aineid en valmistamiseksi
EP2649991B1 (en) Extracts and isolated compounds from Euphorbia granulata Forrsk. for treatment of ulcerative colitis
CN115677471B (zh) 玫瑰烷型二萜类化合物及制备、药物组合物和抗肿瘤应用
CN116693591B (zh) 一个乌苏烷三萜咖啡酸酯化合物的制备与抗肿瘤应用
JP2005314236A (ja) 新規クアシノイド系化合物及びそれらの用途
CN118702626A (zh) 二萜生物碱3-乙酰乌头碱及制备方法、药物组合物和应用
CN1872828B (zh) 单环多取代环己烯醇和酮类化合物及其制备方法与用途
JPH0592990A (ja) カルデノライド誘導体
CN101195616A (zh) 抗肿瘤活性的化合物,其制备方法和其应用
WO1988000826A1 (en) Antitumor compositions and their methods of use
Daoji et al. The purification and structural identification of rhomotoxin
JP2004161728A (ja) ナキテルピオシン誘導体及びこれを有効成分とする抗癌剤
WO1994020511A1 (en) Novel substance doliculide and pharmaceutical use thereof

Legal Events

Date Code Title Description
MA Patent expired